| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| van der Kooi Frederik | Director | C/O CRITEO LEGAL DEPT., 387 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK | /s/ Ryan Damon, as attorney-in-fact for Frederik van der Kooi | 04 Nov 2025 | 0001981335 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRTO | Ordinary Shares | Award | $174,120 | +7,701 | +117% | $22.61 | 14,301 | 03 Nov 2025 | Direct | F1, F2, F3 |
| transaction | CRTO | Ordinary Shares | Purchase | $51,980 | +2,299 | +16% | $22.61 | 16,600 | 03 Nov 2025 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
| F2 | The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person. |
| F3 | For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. |